ARCHIVES

Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week.

This article is from The Cancer Letter archive.

Vol. 30 No. 20 | May 14, 2004

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

New NCAB Chair Seeks Ideas, Opinions On Cancer Priorities

September 23, 1994

National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds

December 3, 1999

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995

Another HHS Recommendation: Screen 50 And Older For Colorectal Cancer;

March 15, 2002

In Brief: AMY ABERNETHY Was Named Chair of a New CancerLinQ Advisory Committee Within the Institute for Quality, An Affiliate Of The American Society of Clinical Oncology.

November 22, 2013